136 related articles for article (PubMed ID: 31835466)
1. Preparation of Squalene Oil-Based Emulsion Adjuvants Employing a Self-Emulsifying Drug Delivery System and Assessment of
Bastola R; Seo JE; Keum T; Noh G; Choi JW; Shin JI; Kim JH; Lee S
Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31835466
[TBL] [Abstract][Full Text] [Related]
2. Determination of Mycoplasma hyopneumoniae-Specific IgG, IgG1, and IgG2a Titers in BALB/c Mice Induced by Mineral Oil-Based Oil-in-Water Emulsion Adjuvants Prepared Using a Self-Emulsifying Drug Delivery System.
Bastola R; Seo JE; Noh G; Keum T; Kim JH; Shin JI; Lee S; Lee S
AAPS PharmSciTech; 2019 Jan; 20(1):31. PubMed ID: 30603786
[TBL] [Abstract][Full Text] [Related]
3. Development of Squalene-Based Oil-in-Water Emulsion Adjuvants Using a Self-Emulsifying Drug Delivery System for Enhanced Antigen-Specific Antibody Titers.
Chae GE; Kim DW; Jin HE
Int J Nanomedicine; 2022; 17():6221-6231. PubMed ID: 36531114
[TBL] [Abstract][Full Text] [Related]
4. Effect of different adjuvant formulations on the immunogenicity and protective effect of a live Mycoplasma hyopneumoniae vaccine after intramuscular inoculation.
Xiong Q; Wei Y; Xie H; Feng Z; Gan Y; Wang C; Liu M; Bai F; Xie F; Shao G
Vaccine; 2014 Jun; 32(27):3445-51. PubMed ID: 24731810
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel oil-in-water emulsion adjuvant for swine influenza virus and Mycoplasma hyopneumoniae vaccines.
Galliher-Beckley A; Pappan LK; Madera R; Burakova Y; Waters A; Nickles M; Li X; Nietfeld J; Schlup JR; Zhong Q; McVey S; Dritz SS; Shi J
Vaccine; 2015 Jun; 33(25):2903-8. PubMed ID: 25936722
[TBL] [Abstract][Full Text] [Related]
6. CpG-mediated augmentation of CD8+ T-cell responses in mice is attenuated by a water-in-oil emulsion (Montanide ISA-51) but enhanced by an oil-in-water emulsion (IDRI SE).
Makinen SR; Zhu Q; Davis HL; Weeratna RD
Int Immunol; 2016 Sep; 28(9):453-61. PubMed ID: 27055469
[TBL] [Abstract][Full Text] [Related]
7. A novel oil-in-water emulsion as a potential adjuvant for influenza vaccine: development, characterization, stability and in vivo evaluation.
Deng J; Cai W; Jin F
Int J Pharm; 2014 Jul; 468(1-2):187-95. PubMed ID: 24704309
[TBL] [Abstract][Full Text] [Related]
8. Immunoenhancement of Recombinant Neisseria meningitides PorB Protein on Porcine Circovirus Type 2 and Mycoplasma hyopneumoniae Genetically Engineered Vaccines.
Yang R; Tao Y; Li G; Chen J; Shu J; He Y
Protein Pept Lett; 2019; 26(10):776-784. PubMed ID: 31208304
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel oil-in-water emulsion and evaluation of its potential adjuvant function in a swine influenza vaccine in mice.
Zhang J; Miao J; Han X; Lu Y; Deng B; Lv F; Zhao Y; Ding C; Hou J
BMC Vet Res; 2018 Dec; 14(1):415. PubMed ID: 30577861
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions.
Fox CB; Baldwin SL; Duthie MS; Reed SG; Vedvick TS
AAPS PharmSciTech; 2012 Jun; 13(2):498-506. PubMed ID: 22415641
[TBL] [Abstract][Full Text] [Related]
11. The development of self-emulsifying oil-in-water emulsion adjuvant and an evaluation of the impact of droplet size on performance.
Shah RR; Dodd S; Schaefer M; Ugozzoli M; Singh M; Otten GR; Amiji MM; O'Hagan DT; Brito LA
J Pharm Sci; 2015 Apr; 104(4):1352-61. PubMed ID: 25600347
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions.
Fox CB; Baldwin SL; Duthie MS; Reed SG; Vedvick TS
Vaccine; 2011 Nov; 29(51):9563-72. PubMed ID: 21906648
[TBL] [Abstract][Full Text] [Related]
13. Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants.
Iyer V; Cayatte C; Guzman B; Schneider-Ohrum K; Matuszak R; Snell A; Rajani GM; McCarthy MP; Muralidhara B
Hum Vaccin Immunother; 2015; 11(7):1853-64. PubMed ID: 26090563
[TBL] [Abstract][Full Text] [Related]
14. Optimising the oil phases of aluminium hydrogel-stabilised emulsions for stable, safe and efficient vaccine adjuvant.
Yuan L; Gao XD; Xia Y
Front Chem Sci Eng; 2022; 16(6):973-984. PubMed ID: 35070473
[TBL] [Abstract][Full Text] [Related]
15. An alternative renewable source of squalene for use in emulsion adjuvants.
Brito LA; Chan M; Baudner B; Gallorini S; Santos G; O'Hagan DT; Singh M
Vaccine; 2011 Aug; 29(37):6262-8. PubMed ID: 21723355
[TBL] [Abstract][Full Text] [Related]
16. Development of pH responsive novel emulsion adjuvant for oral immunization and in vivo evaluation.
Malik B; Gupta RK; Rath G; Goyal AK
Eur J Pharm Biopharm; 2014 Aug; 87(3):589-97. PubMed ID: 24681295
[TBL] [Abstract][Full Text] [Related]
17. Squalane-based emulsion vaccine delivery system: composition with murabutide activate Th1 response.
Kantipakala R; Bonam SR; Vemireddy S; Miryala S; Halmuthur M SK
Pharm Dev Technol; 2019 Mar; 24(3):269-275. PubMed ID: 29688119
[TBL] [Abstract][Full Text] [Related]
18. Liposome-stabilized oil-in-water emulsions as adjuvants: increased emulsion stability promotes induction of cytotoxic T lymphocytes against an HIV envelope antigen.
Richards RL; Rao M; Vancott TC; Matyas GR; Birx DL; Alving CR
Immunol Cell Biol; 2004 Oct; 82(5):531-8. PubMed ID: 15479439
[TBL] [Abstract][Full Text] [Related]
19. The immunogenicity-enhancing effect of emulsion vaccine adjuvants is independent of the dispersion type and antigen release rate--a revisit of the role of the hydrophile-lipophile balance (HLB) value.
Yang YW; Wei AC; Shen SS
Vaccine; 2005 Apr; 23(20):2665-75. PubMed ID: 15780450
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.
Ott G; Barchfeld GL; Van Nest G
Vaccine; 1995 Nov; 13(16):1557-62. PubMed ID: 8578842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
